We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Neurogene
NGNE
$712M
| $202K | ﹤0.01% |
+3,961
| New | +$132K |
|
|
GRND.WS
2677
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
| $201K | ﹤0.01% |
87,000
| – | – |
|
2678
Installed Building Products
IBP
$6.49B
| $200K | ﹤0.01% |
774
-13,856
| -95% | -$2.97M |
|
2679
Rackspace Technology
RXT
$1.24B
| $200K | ﹤0.01% |
126,483
-190,167
| -60% | -$341K |
|
|
TWKS
2680
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $200K | ﹤0.01% |
78,921
-149,163
| -65% | -$572K |
|
2681
Lloyds Banking Group
LYG
$91.3B
| $198K | ﹤0.01% |
76,472
+34,600
| +83% | +$79.4K |
|
2682
Mayville Engineering Co
MEC
$617M
| $198K | ﹤0.01% |
+13,788
| New | +$180K |
|
2683
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$311M
| $197K | ﹤0.01% |
10,900
-1,500
| -12% | -$27.2K |
|
2684
MacroGenics
MGNX
$257M
| $197K | ﹤0.01% |
13,363
-37,700
| -74% | -$570K |
|
2685
Mission Produce
AVO
$1.17B
| $196K | ﹤0.01% |
+16,480
| New | +$176K |
|
2686
Mama's Creations
MAMA
$833M
| $195K | ﹤0.01% |
39,081
+13,864
| +55% | +$65.6K |
|
|
HBI
2687
DELISTED
Hanesbrands
HBI
| $193K | ﹤0.01% |
33,300
-618,643
| -95% | -$2.96M |
|
|
CNSL
2688
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $193K | ﹤0.01% |
44,609
-40,547
| -48% | -$176K |
|
2689
Viasat
VSAT
$11.1B
| $192K | ﹤0.01% |
+10,595
| New | +$222K |
|
2690
Omeros
OMER
$959M
| $189K | ﹤0.01% |
54,918
+7,318
| +15% | +$27.8K |
|
2691
AMC Global Media
AMCX
$489M
| $189K | ﹤0.01% |
+15,601
| New | +$237K |
|
2692
Park Hotels & Resorts
PK
$2.97B
| $188K | ﹤0.01% |
+10,772
| New | +$175K |
|
2693
PUT
Brookdale Senior Living
BKD
$3.4B
| $183K | ﹤0.01% |
27,700
| – | – |
|
2694
Corvus Pharmaceuticals
CRVS
$1.17B
| $182K | ﹤0.01% |
102,449
-78,255
| -43% | -$163K |
|
2695
OmniAb
OABI
$447M
| $181K | ﹤0.01% |
33,447
-13,137
| -28% | -$75.7K |
|
2696
IMAX
IMAX
$2.66B
| $181K | ﹤0.01% |
11,210
-200,423
| -95% | -$3.05M |
|
2697
ProQR Therapeutics
PRQR
$265M
| $181K | ﹤0.01% |
78,944
-20,547
| -21% | -$43.9K |
|
2698
Safe Bulkers
SB
$774M
| $180K | ﹤0.01% |
36,300
-64,044
| -64% | -$282K |
|
2699
Smart Sand
SND
$194M
| $180K | ﹤0.01% |
94,043
-19,386
| -17% | -$37.1K |
|
|
AVDX
2700
DELISTED
AvidXchange
AVDX
| $179K | ﹤0.01% |
13,619
-111,907
| -89% | -$1.34M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.